Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture

Transfusion

Volumn 57, Issue 9, 2017, Pages 2216-2219

  Kaplan, Alesia ^a,b   Sackett, Katie ^c   Sumstad, Darin ^d   Kadidlo, Dianne ^d   McKenna, David H ^c,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; CELL COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KINETICS; MALE; MESENCHYMAL STEM CELL; POTENTIAL DIFFERENCE; PRESCHOOL CHILD; STEM CELL CULTURE; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CYTOLOGY; MESENCHYMAL STROMA CELL;

BONE MARROW; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CRYOPRESERVATION; HUMANS; KINETICS; MESENCHYMAL STROMAL CELLS;

EID: 85021349067     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14192     Document Type: Article

References (17)

1. Sharma RR, Pollock K, Hubel A, et al. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 2014;5:1418-37.
2. Horwitz EM, Gordon PL, Koo WK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci U S A 2002;99:8932-7.
3. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41.
4. Chen SL, Fang WW, Qian J, et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J (Engl) 2004;117:1443-8.
5. Gramlich OW, Burand AJ, Brown AJ, et al. Cryopreserved mesenchymal stromal cells maintain potency in a retinal ischemia/reperfusion injury model: toward an off-the-shelf therapy. Sci Rep 2016;6:26463.
6. Martinello T, Bronzini I, Maccatrozzo L, et al. Cryopreservation does not affect the stem characteristics of multipotent cells isolated from equine peripheral blood. Tissue Eng Part C 2010;16:771-81.
7. Pollock K, Sumstad D, Kadidlo D, et al. Clinical mesenchymal stromal cell products undergo functional changes in response to freezing. Cytotherapy 2015;17:38-45.
8. Luetzkendorf J, Nerger K, Hering J, et al. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation. Cytotherapy 2015;17:186-98.
9. François M, Copland IB, Yuan S, et al. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing. Cytotherapy 2012;14:147-52.
10. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7.
11. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86.
12. Donnenberg AD, Koch EK, Griffin DL, et al. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy 2002;4:157-63.
13. Shima T, Iwasaki H, Yamauchi T, et al. Preserved in vivo reconstitution ability of PBSCs cryopreserved for a decade at −80°C. Bone Marrow Transplant 2015;50:1195-200.
14. Kurita N, Frassoni F, Chiba S, et al. Impact of length of cryopreservation and origin of cord blood units on hematologic recovery following cord blood transplantation. Bone Marrow Transplant 2015;50:818-21.
15. Shen JL, Huang YZ, Xu SX, et al. Effectiveness of human mesenchymal stem cells derived from bone marrow cryopreserved for 23-25 years. Cryobiology 2012;64:167-75.
16. Lane TA, Mackintosh E, Garls D, et al. Marrow stromal cell (MSC) growth from long term cryopreserved bone marrow [abstract]. Blood 2006;108:398b.
17. Casado-Díaz A, Santiago-Mora R, Jiménez R, et al. Cryopreserved human bone marrow mononuclear cells as a source of mesenchymal stromal cells: application in osteoporosis research. Cytotherapy 2008;10:460-8.